In this paper, the goal is to examine elements of philosophy, politics and economics that are inherent to the theory and conduct of cost benefit analysis (CBA), as they emerged in the lectures provided by Brennan and Walsh. An attempt is also made to relate the debates conducted nearly 50 years ago to current developments in the use of CBA in the Australian context.
No takes yet. Share an insight, caveat, or question.
Jeff Bennett (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: